@article{ekenbergAssociationHumanLeukocyte2021a,
  title = {The Association of Human Leukocyte Antigen Alleles with Clinical Disease Progression in {{HIV-positive}} Cohorts with Varied Treatment Strategies},
  author = {Ekenberg, Christina and Reekie, Joanne and Zucco, Adrian G. and Murray, Daniel D. and Sharma, Shweta and Macpherson, Cameron R. and Babiker, Abdel and Kan, Virginia and Lane, H. Clifford and Neaton, James D. and Lundgren, Jens D. and {for the INSIGHT START}, SMART Study Groups},
  year = {2021},
  month = apr,
  journal = {AIDS},
  volume = {35},
  number = {5},
  pages = {783--789},
  issn = {0269-9370},
  doi = {10.1097/QAD.0000000000002800},
  urldate = {2021-08-12},
  abstract = {Objectives:~         The Strategic Timing of AntiRetroviral Treatment (START) and Strategies for Management of Antiretroviral Therapy (SMART) trials demonstrated that ART can partly reverse clinically defined immune dysfunction induced by HIV replication. As control of HIV replication is influenced by the HLA region, we explored whether HLA alleles independently influence the risk of clinical events in HIV+ individuals.         Design:~         Cohort study.         Methods:~         In START and SMART participants, associations between imputed HLA alleles and AIDS, infection-related cancer, herpes virus-related AIDS events, chronic inflammation-related conditions, and bacterial pneumonia were assessed. Cox regression was used to estimate hazard ratios for the risk of events among allele carriers versus noncarriers. Models were adjusted for sex, age, geography, race, time-updated CD4+ T-cell counts and HIV viral load and stratified by treatment group within trials. HLA class I and II alleles were analyzed separately. The Benjamini--Hochberg procedure was used to limit the false discovery rate to less than 5\% (i.e. q value {$<$}0.05).         Results:~         Among 4829 participants, there were 132 AIDS events, 136 chronic inflammation-related conditions, 167 bacterial pneumonias, 45 infection-related cancers, and 49 herpes virus-related AIDS events. Several associations with q value less than 0.05 were found: HLA-DQB1{$\ast$}06:04 and HLA-DRB1{$\ast$}13:02 with AIDS (adjusted HR [95\% CI] 2.63 [1.5--4.6] and 2.25 [1.4--3.7], respectively), HLA-B{$\ast$}15:17 and HLA-DPB1{$\ast$}15:01 with bacterial pneumonia (4.93 [2.3--10.7] and 4.33 [2.0--9.3], respectively), and HLA-A{$\ast$}69:01 with infection-related cancer (15.26 [3.5--66.7]). The carriage frequencies of these alleles were 10\% or less.         Conclusion:~         This hypothesis-generating study suggests that certain HLA alleles may influence the risk of immune dysfunction-related events irrespective of viral load and CD4+ T-cell count.},
  langid = {american},
  file = {C\:\\Users\\rxk865\\OneDrive - University of Copenhagen\\Zotero\\HIV\\Ekenberg et al_2021_The association of human leukocyte antigen alleles with clinical disease.pdf;C\:\\Users\\rxk865\\Zotero\\storage\\IQSUJRA2\\The_association_of_human_leukocyte_antigen_alleles.9.html}
}

@article{ekenbergAssociationSingleNucleotidePolymorphisms2019,
  title = {Association {{Between Single-Nucleotide Polymorphisms}} in {{HLA Alleles}} and {{Human Immunodeficiency Virus Type}} 1 {{Viral Load}} in {{Demographically Diverse}}, {{Antiretroviral Therapy}}--{{Naive Participants From}} the {{Strategic Timing}} of {{AntiRetroviral Treatment Trial}}},
  author = {Ekenberg, Christina and Tang, Man-Hung and Zucco, Adrian G. and Murray, Daniel D. and MacPherson, Cameron Ross and Hu, Xiaojun and Sherman, Brad T. and Losso, Marcelo H. and Wood, Robin and Paredes, Roger and Molina, Jean-Michel and Helleberg, Marie and Jina, Nureen and Kityo, Cissy M. and Florence, Eric and Polizzotto, Mark N. and Neaton, James D. and Lane, H. Clifford and Lundgren, Jens D.},
  year = {2019},
  month = sep,
  journal = {The Journal of Infectious Diseases},
  volume = {220},
  number = {8},
  pages = {1325--1334},
  issn = {0022-1899},
  doi = {10.1093/infdis/jiz294},
  urldate = {2019-10-21},
  abstract = {``To investigate the impact of host genetics on human immunodeficiency virus type 1 control among individuals of different ancestry, we performed genome-wide ass},
  langid = {english},
  file = {C\:\\Users\\rxk865\\OneDrive - University of Copenhagen\\Zotero\\HIV\\Ekenberg et al_2019_Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human.pdf;C\:\\Users\\rxk865\\Zotero\\storage\\792EUY3J\\5521002.html}
}

@article{gabrielaiteHumanImmunotypesImpose2021b,
  title = {Human {{Immunotypes Impose Selection}} on {{Viral Genotypes Through Viral Epitope Specificity}}},
  author = {Gabrielaite, Migle and Bennedb{\ae}k, Marc and Zucco, Adrian G and Ekenberg, Christina and Murray, Daniel D and Kan, Virginia L and Touloumi, Giota and Vandekerckhove, Linos and Turner, Dan and Neaton, James and Lane, H Clifford and Safo, Sandra and {Arenas-Pinto}, Alejandro and Polizzotto, Mark N and G{\"u}nthard, Huldrych F and Lundgren, Jens D and Marvig, Rasmus L and {INSIGHT START Study Group}},
  year = {2021},
  month = dec,
  journal = {The Journal of Infectious Diseases},
  volume = {224},
  number = {12},
  pages = {2053--2063},
  issn = {0022-1899},
  doi = {10.1093/infdis/jiab253},
  urldate = {2022-05-18},
  abstract = {Understanding the genetic interplay between human hosts and infectious pathogens is crucial for how we interpret virulence factors. Here, we tested for associations between HIV and host genetics, and interactive genetic effects on viral load (VL) in HIV-positive antiretroviral treatment-naive clinical trial participants.HIV genomes were sequenced and the encoded amino acid (AA) variants were associated with VL, human single nucleotide polymorphisms (SNPs), and imputed HLA alleles using generalized linear models with Bonferroni correction.Human (388\>501 SNPs) and HIV (3010 variants) genetic data were available for 2122 persons. Four HIV variants were associated with VL (P \&lt;\>1.66\>{\texttimes}\>10--5). Twelve HIV variants were associated with a range of 1--512 human SNPs (P \&lt;\>4.28\>{\texttimes}\>10--11). We found 46 associations between HLA alleles and HIV variants (P \&lt;\>1.29\>{\texttimes}\>10--7). HIV variants and immunotypes when analyzed separately were associated with lower VL, whereas the opposite was true when analyzed in concert. Epitope binding predictions supported our observations.Our results show the importance of immunotype specificity on viral antigenic determinants, and the identified genetic interplay emphasizes that viral and human genetics should be studied in the context of each other.Clinical Trials Registration: NCT00867048.},
  file = {C\:\\Users\\rxk865\\OneDrive - University of Copenhagen\\Zotero\\My_collaborations\\Gabrielaite et al_2021_Human Immunotypes Impose Selection on Viral Genotypes Through Viral Epitope.pdf;C\:\\Users\\rxk865\\Zotero\\storage\\KA4T7PTE\\6273783.html}
}

@article{jensenChestXrayImaging2022,
  title = {Chest X-Ray Imaging Score Is Associated with Severity of {{COVID-19}} Pneumonia: The {{MBrixia}} Score},
  shorttitle = {Chest X-Ray Imaging Score Is Associated with Severity of {{COVID-19}} Pneumonia},
  author = {Jensen, Christian M. and Costa, Junia C. and N{\o}rgaard, Jens C. and Zucco, Adrian G. and Neesgaard, Bastian and Niemann, Carsten U. and Ostrowski, Sisse R. and Reekie, Joanne and Holten, Birgit and Kalhauge, Anna and Matthay, Michael A. and Lundgren, Jens D. and Helleberg, Marie and Moestrup, Kasper S.},
  year = {2022},
  month = dec,
  journal = {Scientific Reports},
  volume = {12},
  number = {1},
  pages = {21019},
  publisher = {Nature Publishing Group},
  issn = {2045-2322},
  doi = {10.1038/s41598-022-25397-7},
  urldate = {2022-12-06},
  abstract = {Spatial resolution in existing chest x-ray (CXR)-based scoring systems for coronavirus disease 2019 (COVID-19) pneumonia is low, and should be increased for better representation of anatomy, and severity of lung involvement. An existing CXR-based system, the Brixia score, was modified to increase the spatial resolution, creating the MBrixia score. The MBrixia score is the sum, of a rule-based quantification of CXR severity on a scale of 0 to 3 in 12 anatomical zones in the lungs. The MBrixia score was applied to CXR images from COVID-19 patients at a single tertiary hospital in the period May 4th--June 5th, 2020. The relationship between MBrixia score, and level of respiratory support at the time of performed CXR imaging was investigated. 37 hospitalized COVID-19 patients with 290 CXRs were identified, 22 (59.5\%) were admitted to the intensive care unit and 10 (27\%) died during follow-up. In a Poisson regression using all 290 MBrixia scored CXRs, a higher MBrixia score was associated with a higher level of respiratory support at the time of performed CXR. The MBrixia score could potentially be valuable as a quantitative surrogate measurement of COVID-19 pneumonia severity, and future studies should investigate the score's validity and capabilities of predicting clinical outcomes.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Respiratory signs and symptoms,Viral infection},
  file = {C\:\\Users\\rxk865\\OneDrive - University of Copenhagen\\Zotero\\My_collaborations\\Jensen et al_2022_Chest x-ray imaging score is associated with severity of COVID-19 pneumonia.pdf;C\:\\Users\\rxk865\\Zotero\\storage\\PW7NKUJ3\\s41598-022-25397-7.html}
}

@article{moestrupReadmissionsPostdischargeMortality2022,
  title = {Readmissions, {{Postdischarge Mortality}}, and {{Sustained Recovery Among Patients Admitted}} to {{Hospital With Coronavirus Disease}} 2019 ({{COVID-19}})},
  author = {Moestrup, Kasper S and Reekie, Joanne and Zucco, Adrian G and Jensen, Tomas {\O} and Jensen, Jens Ulrik S and Wiese, Lothar and Ostrowski, Sisse R and Niemann, Carsten U and MacPherson, Cameron and Lundgren, Jens and Helleberg, Marie},
  year = {2022},
  month = aug,
  journal = {Clinical Infectious Diseases},
  pages = {ciac639},
  issn = {1058-4838},
  doi = {10.1093/cid/ciac639},
  urldate = {2022-09-04},
  abstract = {Many interventional in-patient coronavirus disease 2019 (COVID-19) trials assess primary outcomes through day 28 post-randomization. Since a proportion of patients experience protracted disease or relapse, such follow-up period may not fully capture the course of the disease, even when randomization occurs a few days after hospitalization.Among adults hospitalized with COVID-19 in eastern Denmark from 18 March 2020--12 January 2021 we assessed all-cause mortality, recovery, and sustained recovery 90 days after admission, and readmission and all-cause mortality 90 days after discharge. Recovery was defined as hospital discharge and sustained recovery as recovery and alive without readmissions for 14 consecutive days.Among 3386 patients included in the study, 2796 (82.6\%) reached recovery and 2600 (77.0\%) achieved sustained recovery. Of those discharged from hospital, 556 (19.9\%) were readmitted and 289 (10.3\%) died. Overall, the median time to recovery was 6 days (interquartile range [IQR]: 3--10), and 19 days (IQR: 11--33) among patients in intensive care in the first 2 days of admission.Postdischarge readmission and mortality rates were substantial. Therefore, sustained recovery should be favored to recovery outcomes in clinical COVID-19 trials. A 28-day follow-up period may be too short for the critically ill.},
  file = {C\:\\Users\\rxk865\\OneDrive - University of Copenhagen\\Zotero\\My_collaborations\\Moestrup et al_2022_Readmissions, Postdischarge Mortality, and Sustained Recovery Among Patients.pdf;C\:\\Users\\rxk865\\Zotero\\storage\\N9Q6LWAH\\6658187.html}
}

@article{murrayAssociationTenelevenMethylcytosine2023,
  title = {Association between Ten-Eleven Methylcytosine Dioxygenase 2 Genetic Variation and Viral Load in People with {{HIV}}},
  author = {Murray, Daniel D. and Grund, Birgit and MacPherson, Cameron R. and Ekenberg, Christina and Zucco, Adrian G. and Reekie, Joanne and {Dominguez-Dominguez}, Lourdes and Leung, Preston and Fusco, Dahlene and Gras, Julien and Gerstoft, Jan and Helleberg, Marie and Borges, {\'A}lvaro H. and Polizzotto, Mark N. and Lundgren, Jens D.},
  year = {2023},
  month = mar,
  journal = {AIDS},
  volume = {37},
  number = {3},
  pages = {379},
  issn = {0269-9370},
  doi = {10.1097/QAD.0000000000003427},
  urldate = {2023-03-11},
  abstract = {Introduction:~         Identifying genetic factors that influence HIV-pathogenesis is critical for understanding disease pathways. Previous studies have suggested a role for the human gene ten-eleven methylcytosine dioxygenase 2 (TET2) in modulating HIV-pathogenesis.         Methods:~         We assessed whether genetic variation in TET2 was associated with markers of HIV-pathogenesis using both gene level and single nucleotide polymorphism (SNP) level association in 8512 HIV-positive persons across five clinical trial cohorts.         Results:~         Variation at both the gene and SNP-level of TET2 was found to be associated with levels of HIV viral load (HIV-VL) consistently in the two cohorts that recruited antiretroviral-na{\"i}ve participants. The SNPs occurred in two clusters of high linkage disequilibrium (LD), one associated with high HIV-VL and the other low HIV-VL, and were predominantly found in Black participants.         Conclusion:~         Genetic variation in TET2 was associated with HIV-VL in two large antiretroviral therapy (ART)-naive clinical trial cohorts. The role of TET2 in HIV-pathogenesis warrants further investigation.},
  langid = {american},
  file = {C\:\\Users\\rxk865\\OneDrive - University of Copenhagen\\Zotero\\My_collaborations\\Murray et al_2023_Association between ten-eleven methylcytosine dioxygenase 2 genetic variation.pdf;C\:\\Users\\rxk865\\Zotero\\storage\\9GSWP7I3\\Association_between_ten_eleven_methylcytosine.2.html}
}

@article{norgaardImpactAntibioticTreatment2023a,
  title = {Impact of {{Antibiotic Treatment}} on the {{Gut Microbiome}} and Its {{Resistome}} in {{Hematopoietic Stem Cell Transplant Recipients}}},
  author = {N{\o}rgaard, Jens Christian and J{\o}rgensen, Mette and Moestrup, Kasper Sommerlund and Ilett, Emma Elizabeth and Zucco, Adrian Gabriel and Marandi, Ramtin Z and Julian, Marc Noguera and Paredes, Roger and Lundgren, Jens D and Sengel{\o}v, Henrik and MacPherson, Cameron},
  year = {2023},
  month = jul,
  journal = {The Journal of Infectious Diseases},
  volume = {228},
  number = {1},
  pages = {28--36},
  issn = {0022-1899},
  doi = {10.1093/infdis/jiad033},
  urldate = {2024-10-24},
  abstract = {Antibiotic-resistant bacterial infections are increasingly an issue in allogenic hematopoietic stem cell transplant patients. How antibiotic treatment impacts antibiotic resistance in the human gut microbiome remains poorly understood in vivo. Here, a total of 577 fecal samples from 233 heavily antibiotic-treated transplant patients were examined using high-resolution prescription data and shotgun metagenomics. The 13 most frequently used antibiotics were significantly associated with 154 (40\% of tested associations) microbiome features. Use of broad-spectrum {$\beta$}-lactam antibiotics was most markedly associated with microbial disruption and increase in resistome features. The enterococcal vanA gene was positively associated with 8 of the 13 antibiotics, and in particular piperacillin/tazobactam and vancomycin. Here, we highlight the need for a high-resolution approach in understanding the development of antibiotic resistance in the gut microbiome. Our findings can be used to inform antibiotic stewardship and combat the increasing threat of antibiotic resistance.},
  file = {C\:\\Users\\rxk865\\OneDrive - University of Copenhagen\\Zotero\\My_collaborations\\NÃ¸rgaard et al_2023_Impact of Antibiotic Treatment on the Gut Microbiome and its Resistome in2.pdf;C\:\\Users\\rxk865\\Zotero\\storage\\9BMFKQL8\\7031027.html}
}

@article{rasmussenMetabolicProfilingEarly2023,
  title = {Metabolic {{Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation}} in the {{Context}} of {{CMV Infection}}},
  author = {Rasmussen, Kirstine K. and {dos Santos}, Quenia and MacPherson, Cameron Ross and Zucco, Adrian G. and Gj{\ae}rde, Lars Klingen and Ilett, Emma E. and Lodding, Isabelle and Helleberg, Marie and Lundgren, Jens D. and Nielsen, Susanne D. and Brix, Susanne and Sengel{\o}v, Henrik and Murray, Daniel D.},
  year = {2023},
  month = sep,
  journal = {Metabolites},
  volume = {13},
  number = {9},
  pages = {968},
  publisher = {Multidisciplinary Digital Publishing Institute},
  issn = {2218-1989},
  doi = {10.3390/metabo13090968},
  urldate = {2023-08-29},
  abstract = {Immune dysfunction resulting from allogeneic haematopoietic stem cell transplantation (aHSCT) predisposes one to an elevated risk of cytomegalovirus (CMV) infection. Changes in metabolism have been associated with adverse outcomes, and in this study, we explored the associations between metabolic profiles and post-transplantation CMV infection using plasma samples collected 7--33 days after aHSCT. We included 68 aHSCT recipients from Rigshospitalet, Denmark, 50\% of whom experienced CMV infection between days 34--100 post-transplantation. First, we investigated whether 12 metabolites selected based on the literature were associated with an increased risk of post-transplantation CMV infection. Second, we conducted an exploratory network-based analysis of the complete metabolic and lipidomic profiles in relation to clinical phenotypes and biological pathways. Lower levels of trimethylamine N-oxide were associated with subsequent CMV infection (multivariable logistic regression: OR = 0.63; 95\% CI = [0.41; 0.87]; p = 0.01). Explorative analysis revealed 12 clusters of metabolites or lipids, among which one was predictive of CMV infection, and the others were associated with conditioning regimens, age upon aHSCT, CMV serostatus, and/or sex. Our results provide evidence for an association between the metabolome and CMV infection post-aHSCT that is independent of known risk factors.},
  copyright = {http://creativecommons.org/licenses/by/3.0/},
  langid = {english},
  keywords = {aHSCT,CMV,correlation network analysis,cytomegalovirus,lipidomics,metabolomics,TMAO,WGCNA},
  file = {C:\Users\rxk865\OneDrive - University of Copenhagen\Zotero\My_collaborations\Rasmussen et al_2023_Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation.pdf}
}

@article{svanbergEarlyStimulatedImmune2022,
  title = {Early Stimulated Immune Responses Predict Clinical Disease Severity in Hospitalized {{COVID-19}} Patients},
  author = {Svanberg, Rebecka and MacPherson, Cameron and Zucco, Adrian and Agius, Rudi and Faitova, Tereza and Andersen, Michael Asger and {da Cunha-Bang}, Caspar and Gj{\ae}rde, Lars Klingen and M{\o}ller, Maria Elizabeth Engel and Brooks, Patrick Terrence and Lindegaard, Birgitte and Sejdic, Adin and Gang, Anne Ortved and Hersby, Ditte Stampe and Brieghel, Christian and Nielsen, Susanne Dam and Podlekareva, Daria and Hald, Annemette and Bay, Jakob Thaning and Marquart, Hanne and Lundgren, Jens and Lebech, Anne-Mette and Helleberg, Marie and Niemann, Carsten Utoft and Ostrowski, Sisse Rye},
  year = {2022},
  month = sep,
  journal = {Communications Medicine},
  volume = {2},
  number = {1},
  pages = {1--15},
  publisher = {Nature Publishing Group},
  issn = {2730-664X},
  doi = {10.1038/s43856-022-00178-5},
  urldate = {2022-09-19},
  abstract = {The immune pathogenesis underlying the diverse clinical course of COVID-19 is poorly understood. Currently, there is an unmet need in daily clinical practice for early biomarkers and improved risk stratification tools to help identify and monitor COVID-19 patients at risk of severe disease.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Innate immunity,Viral infection},
  file = {C\:\\Users\\rxk865\\OneDrive - University of Copenhagen\\Zotero\\My_collaborations\\Svanberg et al_2022_Early stimulated immune responses predict clinical disease severity in.pdf;C\:\\Users\\rxk865\\Zotero\\storage\\WLBH2R42\\s43856-022-00178-5.html}
}
